Alfasigma USA, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$414Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
7,163clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2020 $141K
2021 $186K
2022 $87K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Psychiatry $102K
Gastroenterology (Internal Medicine) $94K
Internal Medicine $29K
Endocrinology, Diabetes & Metabolism $27K
Family Medicine $23K
Podiatrist $18K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Vladimir Maletic Greer, SC $17,355.00
Andrew Cutler Lakewood Ranch, FL Psychiatry $15,686.25
John Zajecka Skokie, IL Psychiatry $13,834.38
Elena Christofides Columbus, OH Endocrinology, Diabetes & Metabolism $13,553.19
John Anderson Nashville, TN Internal Medicine $11,792.50
Rakesh Jain Lake Jackson, TX Psychiatry $9,897.50
Valerie Holmes Durham, NC Psychiatry $7,898.75
Richard Shelton Birmingham, AL Psychiatry $7,565.00
Darren Brenner Chicago, IL Gastroenterology (Internal Medicine) $6,585.04
Christopher Bromley Poughkeepsie, NY Podiatrist $6,513.88

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.